TBB BUREAU BHUBANESWAR, JANUARY 14, 2022 It is unlikely that anytime soon, the world will enter into pre-Covid era. Instead, it is likely that we will have to co-exist with Delta and Omicron variants of the Covid-19 in time to come as both these variants will continue to co-circulate. This was stated by virologists and health experts at Neuberg Diagnostics’ ...
Read More »Health
Covaxin booster can neutralise Omicron: Bharat Biotech
TBB BUREAU HYDERABAD, JANUARY 12, 2022 Covaxin’s booster dose is able to neutralise the vaccine evading Omicron variant of Covid-19, according to a study conducted at US’ Emory University, Bharat Biotech announced on Wednesday. The new study demonstrated “sera from subjects who received a booster dose of Covaxin (BBV152) six months after getting a primary two-dose series of Covaxin (BBV152), ...
Read More »COVAXIN booster dose study shows promising results
TBB BUREAU HYDERABAD, JANUARY 8, 2022 Bharat Biotech, a global leader in vaccine innovation and developer of vaccines for infectious diseases, today announced the results from the highly anticipated trial studying the immunogenicity and safety of the COVAXIN (BBV152) a whole-virion inactivated COVID-19 vaccine as a booster dose. This analysis re-emphasizes Bharat Biotech’s continued efforts to stay ahead of COVID-19, ...
Read More »TPCODL launches mobile health dispensary for Cuttack district
TBB BUREAU BHUBANESWAR, JANUARY 7, 2022 TP Central Odisha Distribution Limited (TPCODL), a joint venture between Tata Power and the Government of Odisha, in line with the principle of empowering the community in its area of operations, launched its second Mobile Heath Dispensary for the benefit of rural communities of Cuttack district under its CSR Program. The dispensary was inaugurated ...
Read More »Livinguard technology remains effective against all variants, including Omicron
TBB BUREAU BHUBANESWAR, JANUARY 6, 2021 Since the start of the pandemic, Livinguard, the Swiss-based international leader in sustainable & self-disinfecting hygiene technology, has consistently showcased >99% efficacy against SARS-CoV-2 and its variants, with no recovery of viable viruses, and Omicron will be no different. It has been proven effective against the human coronavirus 229E, the original wild variant of ...
Read More »Shanti Memorial Hospital launches advanced Cath Lab in Cuttack
TBB BUREAU BHUBANESWAR, JANUARY 3, 2022 Cuttack-based Shanti Memorial Hospital has launched a state–of-the-art Cath Lab in its Cardiology Department for the benefit of patients. Procedures like Coronary Angiography, Peripheral Angiography, PTCA, BMV ( Balloon Mitral Valvoplasty), Electrophysiology Study, RFA 2D & 3D Mapping, Permanent Pacemaker Implantation etc. can be performed with ease at the newly launched advanced Cath Lab. ...
Read More »AIIMS Bhubaneswar starts vaccination for 15-18 age group
TBB BUREAU BHUBANESWAR, JANUARY 3, 2022 In a bid to protect the youths of India from the novel coronavirus, the All India Institute of Medical Sciences (AIIMS), Bhubaneswar on Monday started the COVID-19 vaccination drive for the age group 15-18 years. The vaccination session started at 8 AM. There were 150 online registrations and 15 on-the-spot registrations for the same. ...
Read More »ICMR chooses IMS and SUM Hospital as Centre for Clinical Trials
TBB BUREAU BHUBANESWAR, JANUARY 1, 2022 The Indian Council of Medical Research (ICMR) has chosen the Institute of Medical Sciences (IMS) and SUM Hospital in the Capital City of Odisha as one of the ICMR Centre for Clinical Trials (ICCT) in the eastern region. IMS and SUM Hospital, faculty of medicine of Siksha ‘O’ Anusandhan (SOA), had responded to ...
Read More »Dabur enters the Health Food Drink category with ‘Dabur Vita’
TBB BUREAU KOLKATA, DEC 30, 2021 India’s leading Ayurvedic and Natural Health Care Company Dabur India Ltd. announced its foray into the Health Food Drink category with the launch of ‘Dabur Vita’. It is made with a unique blend of more than 30+ herbs Like Ashwagandha, Giloy and Brahmi, which are scientifically proven not only to provide better immunity but ...
Read More »World’s first LAR procedure for Rectal cancer using Medtronic Hugo Robotic-Assisted Surgery System performed at Apollo Hospitals
TBB BUREAU CHENNAI, DEC 21, 2021 The Apollo Hospitals Group today announced the successful completion of the world’s first LAR procedure for rectal cancer and the first GI (gastrointestinal) surgery in the Asia-Pacific region with the Medtronic Hugo robotic-assisted surgery (RAS) system. This milestone in robotic GI surgery was achieved at Apollo Hospitals, Chennai on December 15 by Dr. Venkatesh ...
Read More »